h-header

news

News dal mondo

11

Ago

WHO continues work on quality of medicines

The World Health Organization designates new WHO-Listed Authorities, strengthening global access to quality-assured medical products

WHO has officially designated Health Canada, the Ministry of Health, Labour and Welfare/Pharmaceuticals and Medical Devices Agency (MHLW/PMDA) of Japan, and the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products.

With these latest designations, WHO expands the growing list of WLAs, now involving 39 agencies across the world, supporting faster and broader access to quality-assured medical products, particularly in low- and middle-income countries (LMICs)...[WHO]

15

Ott

AIFA: Online il Rapporto sulle Attività dell'anno 2024

Il Rapporto, pubblicato sul portale dell’Agenzia, presenta i dati e le attività principali...

14

Ott

Critical Medicines Act europeo, nuova proposta di legge per garantire fornitura farmaci e principi attivi

Esponenti del Parlamento europeo insieme alle principali organizzazioni dell’industria farmaceutica...

10

Ott

EMA opens door to reliance on FDA GMP inspections conducted outside the US

The European Medicines Agency (EMA) has begun accepting the Food and Drug Administration’s (FDA)...

10

Ott

EDQM seeks feedback on plans to add glycol adulteration section to monographs

The European Directorate for the Quality of Medicines and HealthCare (EDQM) is holding a consultation...

slider-banner

h-footer